Table 1.
Clinical and demographic data of the participants in the study.
| Variable | Information of Studied Samples n (%) | |||
|---|---|---|---|---|
| Sample type | MS 62 (63.2%) | HC 36 (36.8%) | ||
| Age | 49.41 (23–89) * | 53.47 (35–84) * | ||
| Sex |
Female 43 (69.4%) |
Male 19 (30.6%) |
Female 11 (30.5%) |
Male 25 (69.5%) |
| MS type |
RR 61 (98.4%) |
SP 1 (1.6%) |
- | |
| EDSS |
≥3 15 (24.2%) |
<3 47 (75.8%) |
- | |
| Evolution (years) |
≥15 28 (45.2%) |
<15 34 (54.8%) |
- | |
| DMT |
Treated MS 48 (77.4%) |
Naive MS 14 (22.6%) |
- | |
* Mean (Min-Max); RR: Relapsing-remitting; SP: Secondary progressive; EDSS: Expanded Disability Status Scale; DMT: Disease modifying treatment.